[Form 4] JUPITER NEUROSCIENCES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Jupiter Neurosciences, Inc. director and Chief Scientific Officer Hayward Marshall A. reported multiple equity award exercises that increased his direct common stock holdings. On June 2, 2025 he exercised restricted stock awards and restricted stock units for a combined 789,195 shares of common stock. On March 2, 2026 he exercised a stock option for 225,000 shares of common stock at a conversion price of $0.01 per share, ahead of the option’s March 15, 2026 expiration. In total, the transactions reflect exercises of 1,014,195 shares from derivative awards into common stock, resulting in 2,995,077 common shares held directly after the most recent transaction. Footnotes state that the derivative securities convert into common stock on a one-for-one basis and that certain awards vested upon expiration of the IPO lock-up period or under the company’s 2016 Equity Incentive Plan.

Insider Trade Summary

1,014,195 shares exercised/converted

Mixed 6 txns

Insider Hayward Marshall A.

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	225,000	$0.00	--
Exercise	Common Stock	225,000	--	--
Exercise	Restricted Stock Units	389,793	$0.00	--
Exercise	Restricted Stock Award	399,402	$0.00	--
Exercise	Common Stock	389,793	--	--
Exercise	Common Stock	399,402	--	--

Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Common Stock — 2,995,077 shares (Direct); Restricted Stock Units — 0 shares (Direct); Restricted Stock Award — 0 shares (Direct)

Footnotes (1)

1. These securities convert into common stock on a one-for-one basis. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering. The shares underlying this option vested 100% on January 1, 2016 under the Company's 2016 Equity Incentive Plan.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/13/2026 - 04:01 PM Accepted by SEC EDGAR 07/13/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayward Marshall A.

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

11621 KEW GARDENS AVE, SUITE 210

(Street)

PALM BEACH GARDENS FLORIDA 33410

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2025		M		389,793	A	(1)	2,370,675	D
Common Stock	06/02/2025		M		399,402	A	(1)	2,770,077	D
Common Stock	03/02/2026		M		225,000	A	(3)	2,995,077	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/02/2025		M			389,793	(2)	12/17/2033	Common Stock	389,793	$0.00	0	D
Restricted Stock Award	(1)	06/02/2025		M			399,402	(2)	07/20/2032	Common Stock	399,402	$0.00	0	D
Stock Option (right to buy)	$0.01	03/02/2026		M			225,000	(3)	03/15/2026	Common stock	225,000	$0.00	0	D

Explanation of Responses:

1. These securities convert into common stock on a one-for-one basis.

2. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering.

3. The shares underlying this option vested 100% on January 1, 2016 under the Company's 2016 Equity Incentive Plan.

	/s/ Marshall A. Hayward	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)